As a result of these conflicting findings, this study was conducted to evaluate and compare the levels of serum ACPA in four groups of participants (RAPd, RA, Pd and HC groups) as well as to identify the possible association between RA and Pd by correlating the serum ACPA levels to both clinical RA and Pd parameters. The gene discussed is PRTN3; the disease is rheumatoid arthritis.